0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Viral Vectors Market Research Report 2022
Published Date: August 2022
|
Report Code: QYRE-Auto-9H2963
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Viral Vectors Market Size Status and Forecast 2021 2027

Global Viral Vectors Market Research Report 2022

Code: QYRE-Auto-9H2963
Report
August 2022
97 Pages
QYResearch
Region: Global, North America, Europe, Japan, Central & South America
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
Market Analysis and Insights: Global Viral Vectors Market

The global Viral Vectors market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, Retroviral Vectors accounting for % of the Viral Vectors global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028.

While Cancers segment is altered to an % CAGR throughout this forecast period.
China Viral Vectors market size is valued at US$ million in 2021, while the North America and Europe Viral Vectors are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Viral Vectors landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Viral Vectors market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Viral Vectors market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Viral Vectors market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Viral Vectors market.
Global Viral Vectors Scope and Market Size
Viral Vectors market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Viral Vectors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Retroviral Vectors
Lentiviral Vectors
Adenoviral Vectors
Herpes Simplex Virus Vectors
Chimeric Viral Vectors
Others

Segment by Application

Cancers
Inherited Disorders
Viral Infections
Others

BY REGION

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

BY COMPANY

BioReliance
Cobra Biologics
Oxford BioMedica
UniQure
FinVector
MolMed
MassBiologics
Richter-Helm
FUJIFILM Diosynth Biotechnologies
Lonza
Aldevron
Eurogentec
Cell and Gene Therapy Catapult
Biovian
Thermo Fisher Scientific (Brammer Bio)
VGXI
PlasmidFactory
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Vectors Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Retroviral Vectors
1.2.3 Lentiviral Vectors
1.2.4 Adenoviral Vectors
1.2.5 Herpes Simplex Virus Vectors
1.2.6 Chimeric Viral Vectors
1.2.7 Others
1.3 Market by Application
1.3.1 Global Viral Vectors Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Cancers
1.3.3 Inherited Disorders
1.3.4 Viral Infections
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Viral Vectors Market Perspective (2017-2028)
2.2 Viral Vectors Growth Trends by Region
2.2.1 Viral Vectors Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Viral Vectors Historic Market Size by Region (2017-2022)
2.2.3 Viral Vectors Forecasted Market Size by Region (2023-2028)
2.3 Viral Vectors Market Dynamics
2.3.1 Viral Vectors Industry Trends
2.3.2 Viral Vectors Market Drivers
2.3.3 Viral Vectors Market Challenges
2.3.4 Viral Vectors Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Viral Vectors Players by Revenue
3.1.1 Global Top Viral Vectors Players by Revenue (2017-2022)
3.1.2 Global Viral Vectors Revenue Market Share by Players (2017-2022)
3.2 Global Viral Vectors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Viral Vectors Revenue
3.4 Global Viral Vectors Market Concentration Ratio
3.4.1 Global Viral Vectors Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Vectors Revenue in 2021
3.5 Viral Vectors Key Players Head office and Area Served
3.6 Key Players Viral Vectors Product Solution and Service
3.7 Date of Enter into Viral Vectors Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Viral Vectors Breakdown Data by Type
4.1 Global Viral Vectors Historic Market Size by Type (2017-2022)
4.2 Global Viral Vectors Forecasted Market Size by Type (2023-2028)
5 Viral Vectors Breakdown Data by Application
5.1 Global Viral Vectors Historic Market Size by Application (2017-2022)
5.2 Global Viral Vectors Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Viral Vectors Market Size (2017-2028)
6.2 North America Viral Vectors Market Size by Country (2017-2022)
6.3 North America Viral Vectors Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Viral Vectors Market Size (2017-2028)
7.2 Europe Viral Vectors Market Size by Country (2017-2022)
7.3 Europe Viral Vectors Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Viral Vectors Market Size (2017-2028)
8.2 Asia-Pacific Viral Vectors Market Size by Country (2017-2022)
8.3 Asia-Pacific Viral Vectors Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Viral Vectors Market Size (2017-2028)
9.2 Latin America Viral Vectors Market Size by Country (2017-2022)
9.3 Latin America Viral Vectors Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Viral Vectors Market Size (2017-2028)
10.2 Middle East & Africa Viral Vectors Market Size by Country (2017-2022)
10.3 Middle East & Africa Viral Vectors Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 BioReliance
11.1.1 BioReliance Company Detail
11.1.2 BioReliance Business Overview
11.1.3 BioReliance Viral Vectors Introduction
11.1.4 BioReliance Revenue in Viral Vectors Business (2017-2022)
11.1.5 BioReliance Recent Development
11.2 Cobra Biologics
11.2.1 Cobra Biologics Company Detail
11.2.2 Cobra Biologics Business Overview
11.2.3 Cobra Biologics Viral Vectors Introduction
11.2.4 Cobra Biologics Revenue in Viral Vectors Business (2017-2022)
11.2.5 Cobra Biologics Recent Development
11.3 Oxford BioMedica
11.3.1 Oxford BioMedica Company Detail
11.3.2 Oxford BioMedica Business Overview
11.3.3 Oxford BioMedica Viral Vectors Introduction
11.3.4 Oxford BioMedica Revenue in Viral Vectors Business (2017-2022)
11.3.5 Oxford BioMedica Recent Development
11.4 UniQure
11.4.1 UniQure Company Detail
11.4.2 UniQure Business Overview
11.4.3 UniQure Viral Vectors Introduction
11.4.4 UniQure Revenue in Viral Vectors Business (2017-2022)
11.4.5 UniQure Recent Development
11.5 FinVector
11.5.1 FinVector Company Detail
11.5.2 FinVector Business Overview
11.5.3 FinVector Viral Vectors Introduction
11.5.4 FinVector Revenue in Viral Vectors Business (2017-2022)
11.5.5 FinVector Recent Development
11.6 MolMed
11.6.1 MolMed Company Detail
11.6.2 MolMed Business Overview
11.6.3 MolMed Viral Vectors Introduction
11.6.4 MolMed Revenue in Viral Vectors Business (2017-2022)
11.6.5 MolMed Recent Development
11.7 MassBiologics
11.7.1 MassBiologics Company Detail
11.7.2 MassBiologics Business Overview
11.7.3 MassBiologics Viral Vectors Introduction
11.7.4 MassBiologics Revenue in Viral Vectors Business (2017-2022)
11.7.5 MassBiologics Recent Development
11.8 Richter-Helm
11.8.1 Richter-Helm Company Detail
11.8.2 Richter-Helm Business Overview
11.8.3 Richter-Helm Viral Vectors Introduction
11.8.4 Richter-Helm Revenue in Viral Vectors Business (2017-2022)
11.8.5 Richter-Helm Recent Development
11.9 FUJIFILM Diosynth Biotechnologies
11.9.1 FUJIFILM Diosynth Biotechnologies Company Detail
11.9.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.9.3 FUJIFILM Diosynth Biotechnologies Viral Vectors Introduction
11.9.4 FUJIFILM Diosynth Biotechnologies Revenue in Viral Vectors Business (2017-2022)
11.9.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.10 Lonza
11.10.1 Lonza Company Detail
11.10.2 Lonza Business Overview
11.10.3 Lonza Viral Vectors Introduction
11.10.4 Lonza Revenue in Viral Vectors Business (2017-2022)
11.10.5 Lonza Recent Development
11.11 Aldevron
11.11.1 Aldevron Company Detail
11.11.2 Aldevron Business Overview
11.11.3 Aldevron Viral Vectors Introduction
11.11.4 Aldevron Revenue in Viral Vectors Business (2017-2022)
11.11.5 Aldevron Recent Development
11.12 Eurogentec
11.12.1 Eurogentec Company Detail
11.12.2 Eurogentec Business Overview
11.12.3 Eurogentec Viral Vectors Introduction
11.12.4 Eurogentec Revenue in Viral Vectors Business (2017-2022)
11.12.5 Eurogentec Recent Development
11.13 Cell and Gene Therapy Catapult
11.13.1 Cell and Gene Therapy Catapult Company Detail
11.13.2 Cell and Gene Therapy Catapult Business Overview
11.13.3 Cell and Gene Therapy Catapult Viral Vectors Introduction
11.13.4 Cell and Gene Therapy Catapult Revenue in Viral Vectors Business (2017-2022)
11.13.5 Cell and Gene Therapy Catapult Recent Development
11.14 Biovian
11.14.1 Biovian Company Detail
11.14.2 Biovian Business Overview
11.14.3 Biovian Viral Vectors Introduction
11.14.4 Biovian Revenue in Viral Vectors Business (2017-2022)
11.14.5 Biovian Recent Development
11.15 Thermo Fisher Scientific (Brammer Bio)
11.15.1 Thermo Fisher Scientific (Brammer Bio) Company Detail
11.15.2 Thermo Fisher Scientific (Brammer Bio) Business Overview
11.15.3 Thermo Fisher Scientific (Brammer Bio) Viral Vectors Introduction
11.15.4 Thermo Fisher Scientific (Brammer Bio) Revenue in Viral Vectors Business (2017-2022)
11.15.5 Thermo Fisher Scientific (Brammer Bio) Recent Development
11.16 VGXI
11.16.1 VGXI Company Detail
11.16.2 VGXI Business Overview
11.16.3 VGXI Viral Vectors Introduction
11.16.4 VGXI Revenue in Viral Vectors Business (2017-2022)
11.16.5 VGXI Recent Development
11.17 PlasmidFactory
11.17.1 PlasmidFactory Company Detail
11.17.2 PlasmidFactory Business Overview
11.17.3 PlasmidFactory Viral Vectors Introduction
11.17.4 PlasmidFactory Revenue in Viral Vectors Business (2017-2022)
11.17.5 PlasmidFactory Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Viral Vectors Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Retroviral Vectors
    Table 3. Key Players of Lentiviral Vectors
    Table 4. Key Players of Adenoviral Vectors
    Table 5. Key Players of Herpes Simplex Virus Vectors
    Table 6. Key Players of Chimeric Viral Vectors
    Table 7. Key Players of Others
    Table 8. Global Viral Vectors Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Viral Vectors Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 10. Global Viral Vectors Market Size by Region (2017-2022) & (US$ Million)
    Table 11. Global Viral Vectors Market Share by Region (2017-2022)
    Table 12. Global Viral Vectors Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 13. Global Viral Vectors Market Share by Region (2023-2028)
    Table 14. Viral Vectors Market Trends
    Table 15. Viral Vectors Market Drivers
    Table 16. Viral Vectors Market Challenges
    Table 17. Viral Vectors Market Restraints
    Table 18. Global Viral Vectors Revenue by Players (2017-2022) & (US$ Million)
    Table 19. Global Viral Vectors Market Share by Players (2017-2022)
    Table 20. Global Top Viral Vectors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vectors as of 2021)
    Table 21. Ranking of Global Top Viral Vectors Companies by Revenue (US$ Million) in 2021
    Table 22. Global 5 Largest Players Market Share by Viral Vectors Revenue (CR5 and HHI) & (2017-2022)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Viral Vectors Product Solution and Service
    Table 25. Date of Enter into Viral Vectors Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Viral Vectors Market Size by Type (2017-2022) & (US$ Million)
    Table 28. Global Viral Vectors Revenue Market Share by Type (2017-2022)
    Table 29. Global Viral Vectors Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 30. Global Viral Vectors Revenue Market Share by Type (2023-2028)
    Table 31. Global Viral Vectors Market Size by Application (2017-2022) & (US$ Million)
    Table 32. Global Viral Vectors Revenue Market Share by Application (2017-2022)
    Table 33. Global Viral Vectors Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 34. Global Viral Vectors Revenue Market Share by Application (2023-2028)
    Table 35. North America Viral Vectors Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Viral Vectors Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Viral Vectors Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Europe Viral Vectors Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Asia-Pacific Viral Vectors Market Size by Region (2017-2022) & (US$ Million)
    Table 40. Asia-Pacific Viral Vectors Market Size by Region (2023-2028) & (US$ Million)
    Table 41. Latin America Viral Vectors Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Latin America Viral Vectors Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Middle East & Africa Viral Vectors Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Middle East & Africa Viral Vectors Market Size by Country (2023-2028) & (US$ Million)
    Table 45. BioReliance Company Detail
    Table 46. BioReliance Business Overview
    Table 47. BioReliance Viral Vectors Product
    Table 48. BioReliance Revenue in Viral Vectors Business (2017-2022) & (US$ Million)
    Table 49. BioReliance Recent Development
    Table 50. Cobra Biologics Company Detail
    Table 51. Cobra Biologics Business Overview
    Table 52. Cobra Biologics Viral Vectors Product
    Table 53. Cobra Biologics Revenue in Viral Vectors Business (2017-2022) & (US$ Million)
    Table 54. Cobra Biologics Recent Development
    Table 55. Oxford BioMedica Company Detail
    Table 56. Oxford BioMedica Business Overview
    Table 57. Oxford BioMedica Viral Vectors Product
    Table 58. Oxford BioMedica Revenue in Viral Vectors Business (2017-2022) & (US$ Million)
    Table 59. Oxford BioMedica Recent Development
    Table 60. UniQure Company Detail
    Table 61. UniQure Business Overview
    Table 62. UniQure Viral Vectors Product
    Table 63. UniQure Revenue in Viral Vectors Business (2017-2022) & (US$ Million)
    Table 64. UniQure Recent Development
    Table 65. FinVector Company Detail
    Table 66. FinVector Business Overview
    Table 67. FinVector Viral Vectors Product
    Table 68. FinVector Revenue in Viral Vectors Business (2017-2022) & (US$ Million)
    Table 69. FinVector Recent Development
    Table 70. MolMed Company Detail
    Table 71. MolMed Business Overview
    Table 72. MolMed Viral Vectors Product
    Table 73. MolMed Revenue in Viral Vectors Business (2017-2022) & (US$ Million)
    Table 74. MolMed Recent Development
    Table 75. MassBiologics Company Detail
    Table 76. MassBiologics Business Overview
    Table 77. MassBiologics Viral Vectors Product
    Table 78. MassBiologics Revenue in Viral Vectors Business (2017-2022) & (US$ Million)
    Table 79. MassBiologics Recent Development
    Table 80. Richter-Helm Company Detail
    Table 81. Richter-Helm Business Overview
    Table 82. Richter-Helm Viral Vectors Product
    Table 83. Richter-Helm Revenue in Viral Vectors Business (2017-2022) & (US$ Million)
    Table 84. Richter-Helm Recent Development
    Table 85. FUJIFILM Diosynth Biotechnologies Company Detail
    Table 86. FUJIFILM Diosynth Biotechnologies Business Overview
    Table 87. FUJIFILM Diosynth Biotechnologies Viral Vectors Product
    Table 88. FUJIFILM Diosynth Biotechnologies Revenue in Viral Vectors Business (2017-2022) & (US$ Million)
    Table 89. FUJIFILM Diosynth Biotechnologies Recent Development
    Table 90. Lonza Company Detail
    Table 91. Lonza Business Overview
    Table 92. Lonza Viral Vectors Product
    Table 93. Lonza Revenue in Viral Vectors Business (2017-2022) & (US$ Million)
    Table 94. Lonza Recent Development
    Table 95. Aldevron Company Detail
    Table 96. Aldevron Business Overview
    Table 97. Aldevron Viral VectorsProduct
    Table 98. Aldevron Revenue in Viral Vectors Business (2017-2022) & (US$ Million)
    Table 99. Aldevron Recent Development
    Table 100. Eurogentec Company Detail
    Table 101. Eurogentec Business Overview
    Table 102. Eurogentec Viral VectorsProduct
    Table 103. Eurogentec Revenue in Viral Vectors Business (2017-2022) & (US$ Million)
    Table 104. Eurogentec Recent Development
    Table 105. Cell and Gene Therapy Catapult Company Detail
    Table 106. Cell and Gene Therapy Catapult Business Overview
    Table 107. Cell and Gene Therapy Catapult Viral VectorsProduct
    Table 108. Cell and Gene Therapy Catapult Revenue in Viral Vectors Business (2017-2022) & (US$ Million)
    Table 109. Cell and Gene Therapy Catapult Recent Development
    Table 110. Biovian Company Detail
    Table 111. Biovian Business Overview
    Table 112. Biovian Viral VectorsProduct
    Table 113. Biovian Revenue in Viral Vectors Business (2017-2022) & (US$ Million)
    Table 114. Biovian Recent Development
    Table 115. Thermo Fisher Scientific (Brammer Bio) Company Detail
    Table 116. Thermo Fisher Scientific (Brammer Bio) Business Overview
    Table 117. Thermo Fisher Scientific (Brammer Bio) Viral VectorsProduct
    Table 118. Thermo Fisher Scientific (Brammer Bio) Revenue in Viral Vectors Business (2017-2022) & (US$ Million)
    Table 119. Thermo Fisher Scientific (Brammer Bio) Recent Development
    Table 120. VGXI Company Detail
    Table 121. VGXI Business Overview
    Table 122. VGXI Viral VectorsProduct
    Table 123. VGXI Revenue in Viral Vectors Business (2017-2022) & (US$ Million)
    Table 124. VGXI Recent Development
    Table 125. PlasmidFactory Company Detail
    Table 126. PlasmidFactory Business Overview
    Table 127. PlasmidFactory Viral VectorsProduct
    Table 128. PlasmidFactory Revenue in Viral Vectors Business (2017-2022) & (US$ Million)
    Table 129. PlasmidFactory Recent Development
    Table 130. Research Programs/Design for This Report
    Table 131. Key Data Information from Secondary Sources
    Table 132. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Viral Vectors Market Share by Type: 2021 VS 2028
    Figure 2. Retroviral Vectors Features
    Figure 3. Lentiviral Vectors Features
    Figure 4. Adenoviral Vectors Features
    Figure 5. Herpes Simplex Virus Vectors Features
    Figure 6. Chimeric Viral Vectors Features
    Figure 7. Others Features
    Figure 8. Global Viral Vectors Market Share by Application in 2021 & 2028
    Figure 9. Cancers Case Studies
    Figure 10. Inherited Disorders Case Studies
    Figure 11. Viral Infections Case Studies
    Figure 12. Others Case Studies
    Figure 13. Viral Vectors Report Years Considered
    Figure 14. Global Viral Vectors Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 15. Global Viral Vectors Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Viral Vectors Market Share by Region: 2021 VS 2028
    Figure 17. Global Viral Vectors Market Share by Players in 2021
    Figure 18. Global Top Viral Vectors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vectors as of 2021)
    Figure 19. The Top 10 and 5 Players Market Share by Viral Vectors Revenue in 2021
    Figure 20. North America Viral Vectors Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. North America Viral Vectors Market Share by Country (2017-2028)
    Figure 22. United States Viral Vectors Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Canada Viral Vectors Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Viral Vectors Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Europe Viral Vectors Market Share by Country (2017-2028)
    Figure 26. Germany Viral Vectors Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. France Viral Vectors Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. U.K. Viral Vectors Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Italy Viral Vectors Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Russia Viral Vectors Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Nordic Countries Viral Vectors Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Viral Vectors Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Viral Vectors Market Share by Region (2017-2028)
    Figure 34. China Viral Vectors Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Japan Viral Vectors Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. South Korea Viral Vectors Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Southeast Asia Viral Vectors Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. India Viral Vectors Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Australia Viral Vectors Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Latin America Viral Vectors Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Latin America Viral Vectors Market Share by Country (2017-2028)
    Figure 42. Mexico Viral Vectors Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Brazil Viral Vectors Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Middle East & Africa Viral Vectors Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Middle East & Africa Viral Vectors Market Share by Country (2017-2028)
    Figure 46. Turkey Viral Vectors Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Saudi Arabia Viral Vectors Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. BioReliance Revenue Growth Rate in Viral Vectors Business (2017-2022)
    Figure 49. Cobra Biologics Revenue Growth Rate in Viral Vectors Business (2017-2022)
    Figure 50. Oxford BioMedica Revenue Growth Rate in Viral Vectors Business (2017-2022)
    Figure 51. UniQure Revenue Growth Rate in Viral Vectors Business (2017-2022)
    Figure 52. FinVector Revenue Growth Rate in Viral Vectors Business (2017-2022)
    Figure 53. MolMed Revenue Growth Rate in Viral Vectors Business (2017-2022)
    Figure 54. MassBiologics Revenue Growth Rate in Viral Vectors Business (2017-2022)
    Figure 55. Richter-Helm Revenue Growth Rate in Viral Vectors Business (2017-2022)
    Figure 56. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Viral Vectors Business (2017-2022)
    Figure 57. Lonza Revenue Growth Rate in Viral Vectors Business (2017-2022)
    Figure 58. Aldevron Revenue Growth Rate in Viral Vectors Business (2017-2022)
    Figure 59. Eurogentec Revenue Growth Rate in Viral Vectors Business (2017-2022)
    Figure 60. Cell and Gene Therapy Catapult Revenue Growth Rate in Viral Vectors Business (2017-2022)
    Figure 61. Biovian Revenue Growth Rate in Viral Vectors Business (2017-2022)
    Figure 62. Thermo Fisher Scientific (Brammer Bio) Revenue Growth Rate in Viral Vectors Business (2017-2022)
    Figure 63. VGXI Revenue Growth Rate in Viral Vectors Business (2017-2022)
    Figure 64. PlasmidFactory Revenue Growth Rate in Viral Vectors Business (2017-2022)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$2900
This license allows only one user to access the PDF.

Electronic (PDF)
$4350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$5800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SecuX Technology Inc
SIMILAR REPORTS